Institute for Stem Cell Biology and Regenerative Medicine

CytoTRACE 2: AI modeling of individual cell potential creates a vast space for new discoveries in cancer and developmental biology

In recent years, the Newman lab has been a foundry for advanced scientific tools. The analytical methods the lab has developed have empowered biological researchers around the world and let to exciting new discoveries.

Institute for Stem Cell Biology and Regenerative Medicine

ISCBRM Awards $1.55 Million in Grants to Advance Stem Cell Research.

On July 23rd, 2025, the Institute for Stem Cell Biology and Regenerative Medicine announced the recipients of three prestigious funding programs supporting innovative research in stem cell biology and regenerative medicine.

News Center

Stem cell transplant without toxic preparation successfully treats genetic disease

An antibody developed at Stanford Medicine can prepare patients for stem cell transplantation, sparing them toxic side effects, a Phase 1 clinical trial found.

California Life Sciences

California Life Sciences Announces Winners of 21st Annual Pantheon Awards - California Life Sciences

With your votes and others, California Life Sciences awarded Stanford's ISCBRM the Academia, Non-Profit, & Research Award! This award was part of the Pantheon Awards.

Scope

How music gives aspiring physician-scientist a proper life rhythm

Quenton Rashawn Bubb continues to value the complex, complementary nature of work on parallel paths -- not just as a musician/academic, but now on the path to his career.

Institute for Stem Cell Biology and Regenerative Medicine

A twist on developmental regulation of the face

During development, transcription factors are important in unlocking genes and making them available to cellular machinery. Joanna Wysocka and her colleagues found a novel sequence that allows coordination between different transcription factors during the development of the face.

News Center

Hodgkin lymphoma prognosis, biology tracked with circulating tumor DNA

Circulating tumor DNA predicts recurrence and splits disease into two subgroups in Stanford Medicine-led study of Hodgkin lymphoma. New drug targets or changes in treatments may reduce toxicity.

Institute for Stem Cell Biology
and Regenerative Medicine

Why does CHIP lead to cardiovascular disease? The answers are becoming clearer

Stem cell mutations that lead to dominant clones raise the risk of cardiovascular disease. The mechanisms of this increased risk may like in the promotion of inflammatory activities among the offspring of mutant stem cells.

Scope

Blood condition linked to protection against Alzheimer's

Researchers at Stanford Medicine explore a potentially causative connection between a blood disorder called CHP and Alzheimer's disease..

Institute for Stem Cell Biology
and Regenerative Medicine

Growing new blood vessels when arteries are blocked

Institute researchers have discovered that certain purified stem cell components of normal fat, when combined in the right proportions and transplanted into the body, will grow into new blood vessels. The researchers showed that when the technique was used in mice it restored blood flow to areas where areas where arteries were blocked

Institute for Stem Cell Biology
and Regenerative Medicine

Researchers expand human blood stem cells in culture

For decades, researchers have been trying to expand human blood stem cells in culture. Researchers at the institute have recently accomplished this, opening the way to explore many new medical therapies and avenues of basic research.

Video: Viral DNA is crucial to human development

Seminars


REMS seminars are held on Thursdays at noon